Galectin Therapeutics
GALT
#8462
Rank
โ‚ฌ0.24 B
Marketcap
2,45ย โ‚ฌ
Share price
-4.27%
Change (1 day)
-47.21%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): -0,40ย โ‚ฌ

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -0,43ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,44ย โ‚ฌ an increase over its 2024 EPS that were of -0,69ย โ‚ฌ.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,40ย โ‚ฌ-7.59%
2025-0,44ย โ‚ฌ-36.84%
2024-0,69ย โ‚ฌ2.7%
2023-0,67ย โ‚ฌ13.85%
2022-0,59ย โ‚ฌ25%
2021-0,47ย โ‚ฌ26.83%
2020-0,37ย โ‚ฌ5.13%
2019-0,36ย โ‚ฌ2.63%
2018-0,35ย โ‚ฌ-22.45%
2017-0,45ย โ‚ฌ-35.53%
2016-0,69ย โ‚ฌ-13.64%
2015-0,80ย โ‚ฌ12.82%
2014-0,71ย โ‚ฌ-40%
2013-1,19ย โ‚ฌ80.56%
2012-0,66ย โ‚ฌ-32.08%
2011-0,97ย โ‚ฌ13.98%
2010-0,85ย โ‚ฌ-22.5%
2009-1,09ย โ‚ฌ185.71%
2008-0,38ย โ‚ฌ-70.83%
2007-1,31ย โ‚ฌ118.18%
2006-0,60ย โ‚ฌ-54.17%
2005-1,31ย โ‚ฌ-14.29%
2004-1,53ย โ‚ฌ47.37%
2003-1,04ย โ‚ฌ-13.64%
2002-1,20ย โ‚ฌ-24.14%
2001-1,59ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-11,14ย โ‚ฌ 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-0,12ย โ‚ฌ-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA